Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

23
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
23
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

79
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
79
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

695
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
695
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

258
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
258
Inflammation01:38

Inflammation

52.2K
Overview
52.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracoronary Thrombolysis During Primary PCI for STEMI: An Updated Meta-Analysis of Randomized-Controlled Trials.

The American journal of cardiology·2026
Same author

Risk of Depression With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Compared to Other Antidiabetic Medications in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Cureus·2026
Same author

Melatonin Supplementation and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials.

Journal of clinical medicine·2026
Same author

Association Between Vericiguat and Clinical Outcomes Across Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Reviews in cardiovascular medicine·2026
Same author

Anticoagulation De-escalation After Atrial Fibrillation Ablation: Evidence From the OCEAN and ALONE-AF Randomized Trials.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Predicting acute kidney injury in septic shock patients using inflammatory indices in the intensive care unit.

World journal of critical care medicine·2026

Related Experiment Video

Updated: May 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K

Elevated C-reactive protein and cardiovascular risk.

Jia Ee Chia1, Song Peng Ang2

  • 1Department of Medicine, Texas Tech University Health Science Center, El Paso, Texas.

Current Opinion in Cardiology
|February 27, 2025
PubMed
Summary

C-reactive protein (CRP) is a key inflammation biomarker in cardiovascular disease (CVD). While therapies targeting CRP show promise, further research is needed to clarify its causal role and optimize its use in personalized CVD management.

Keywords:
C-reactive proteincardiovascularinflammationprognosistherapy

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

Related Experiment Videos

Last Updated: May 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biomarkers
  • Clinical Research

Background:

  • C-reactive protein (CRP) is a crucial inflammation marker in cardiovascular disease (CVD).
  • Its role in pathogenesis involves endothelial dysfunction, oxidative stress, and plaque destabilization.
  • Understanding CRP's evolving significance is vital for cardiovascular health.

Purpose of the Study:

  • To critically review the dynamic role of CRP in cardiovascular disease (CVD).
  • To examine CRP's pathogenesis and its association with coronary artery disease (CAD), heart failure, and atrial fibrillation.
  • To assess the clinical utility and future directions of CRP in CVD management.

Main Methods:

  • Systematic literature review of recent studies on CRP in CVD.
  • Analysis of mechanistic links between CRP and cardiovascular pathologies.
  • Evaluation of clinical trial data on CRP-lowering therapies and guideline recommendations.

Main Results:

  • CRP is mechanistically linked to endothelial dysfunction, oxidative stress, and plaque instability.
  • Lipid-lowering and anti-inflammatory agents reduce CRP and improve outcomes in CAD.
  • Elevated CRP predicts adverse events in heart failure; novel therapies lower CRP.
  • CRP correlates with atrial fibrillation outcomes, but data are inconsistent.
  • Guidelines differ on CRP's role in risk stratification and primary prevention.

Conclusions:

  • CRP remains a pivotal inflammation biomarker in CVD, but its causal role needs clarification.
  • CRP-guided therapies show potential, but robust trials are needed to confirm direct outcome benefits.
  • Future research should focus on CRP's mechanisms and its validation in personalized CVD management.